Brought to you by 
Midatech completes £32mm IPO in London
22 Sep 2017
Executive Summary
Nanomedicines company Midatech Pharma PLC grossed £32mm ($50mm) through its IPO of 12mm shares for £2.67 on the London Stock Exchange’s AIM Market. Following the closing, the company’s major stockholders now include Woodford Fund Management (19.99%), Arrowgrass Capital Partners (5.3%), Legal & General Investment Management (4%), and Octopus Investments (3.6%).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Site Specific
-
Drug Delivery
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Midatech completes £32mm IPO in London
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice